In sum, a multitude of groups have associated AML1/ETO with the recruitment of transcription factors and chromatin-modifying enzymes and consequently, genome-wide histone modifications, supporting the general role of AML1/ETO as an important epigenetic modifier in leukemia [69–73]. This evidence concerns the gene RUNX1T1 and leukemia.